✦ LIBER ✦

Preclinical Cardiovascular Safety Evaluations of Biologics

✍ Scribed by Hondeghem, Luc; Clerck, Fred

Book ID: 121644512
Publisher: Springer International Publishing AG
Year: 2012
Tongue: English
Weight: 148 KB
Volume: 26
Category: Article
ISSN: 1173-8804
DOI: 10.1007/BF03261886

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Scientific review and recommendations on

Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics

✍ Hugo M. Vargas; Alan S. Bass; Alexander Breidenbach; Hal S. Feldman; Gary A. Gin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Preclinical evaluation of the immunologi

Preclinical evaluation of the immunological safety of biologics

✍ Jacques Descotes 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Scientific and regulatory approaches for

Scientific and regulatory approaches for the preclinical safety evaluation of biologics

✍ Claudio Bernardi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Preclinical development of therapeutic b

Preclinical development of therapeutic biologics

✍ Baumann, Andreas 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 153 KB

Preclinical Safety Evaluation of Biophar

Preclinical Safety Evaluation of Biopharmaceuticals || Preclinical Safety Study Design Templates and Estimated Costs

✍ Cavagnaro, Joy A. 📂 Article 📅 2008 🏛 John Wiley & Sons, Inc. ⚖ 336 KB

Preclinical Safety Evaluation of Biophar

Preclinical Safety Evaluation of Biopharmaceuticals || Use of Animal Models of Disease in the Preclinical Safety Evaluation of Biopharmaceuticals

✍ Cavagnaro, Joy A. 📂 Article 📅 2008 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 210 KB

the Goal Is To Provide A Comprehensive Reference Book For The Preclinicaldiscovery And Development Scientist Whose Responsibilities Span Target Identification, Lead Candidate Selection, Pharmacokinetics, Pharmacology, And Toxicology, And For Regulatory Scientists Whose Responsibilities Include The E